Buscar
Mostrando ítems 21-30 de 91
Trabajos presentados en eventos
Evaluation of Humoral Response to SARS-CoV-2 after Two-Doses of the ChAdOx1 nCoV-19 Vaccine (Astrazeneca) in a Cohort from Rio de Janeiro, Brazil
| Fecha del documento:
2022 | Derechos de autor:
open access
Trabajos presentados en eventos
Pharmacovigilance Committee for COVID-19 vaccine (ChAdOx1-S [recombinant]) and its contribution for an effective benefit-risk assessment
| Fecha del documento:
2022 | Derechos de autor:
open access
Trabajos presentados en eventos
Development of a rapid test for detection of anti-COVID-19 IgG and IgM antibodies
| Fecha del documento:
2021 | Derechos de autor:
open access
Trabajos presentados en eventos
Assessment of humoral response to SARS-CoV-2 using an ELISA kit, developed and validated at references laboratories in Brazil
| Fecha del documento:
2021 | Derechos de autor:
open access
Trabajos presentados en eventos
Situational strategic planning of the pharmacovigilance of Covid-19 vaccine (ChAdOx1-S [recombinant]) at Bio-Manguinhos/Fiocruz
| Fecha del documento:
2021 | Derechos de autor:
open access
Trabajos presentados en eventos
Technology foresight for identification of opportunities and partnerships in COVID-19 vaccines, biotherapeutics and diagnostics test
| Fecha del documento:
2021 | Derechos de autor:
open access
Trabajos presentados en eventos
Continued Process Verification for COVID-19 Vaccine Formulation and Packaging (recombinant)
| Fecha del documento:
2022 | Derechos de autor:
open access
Trabajos presentados en eventos
Development of human angiotensin converting enzyme-2 (hACE2) as a strategy to face COVID-19
| Fecha del documento:
2021 | Derechos de autor:
open access
Trabajos presentados en eventos
Determining identity, purity and activity of Benzonase® endonuclease applied on the Recombinant Covid-19 Vaccine active pharmaceutical ingredient production
| Fecha del documento:
2022 | Derechos de autor:
open access
Trabajos presentados en eventos
Virucidal activity evaluation of hydrogen peroxide wipes against the AZD1222-chimpanzee adenovirus in active pharmaceutical ingredient and the recombinant COVID-19 vaccine
| Fecha del documento:
2022 | Derechos de autor:
open access